Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 4 2Phase 3 2Phase NA 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Polycystic Ovary Syndrome 4Breast Neoplasms 2Obesity 1Heart Failure 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × dapagliflozin × Clear all
NCT06304857 2024-12-04

PROTECTAA

4th Military Clinical Hospital with Polyclinic, Poland

Phase 3 Recruiting
188 enrolled
Breast

Breast Neoplasms, Heart Failure

NCT06711185 2024-12-02

DAPA-MYOCANCER

University of Campinas, Brazil

Phase 3 Recruiting
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡